Institutional Ownership
Relmada Therapeutics Inc
CUSIP 75955J402COMRLMDQ1 2026
13D / 13G Filings
41
Schedule 13D/13G on record
Beneficial Filers
18
Distinct reporting persons
Largest Stake
11.0%
Max % of class reported
Institutional Holders
100
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
41 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | Squadron Master Fund LP | 13G/A | 9.9% | 7.40M | SEC |
| 2 | Feb 17, 2026 | Spruce Street Capital LP | 13G | 5.6% | 4.09M | SEC |
| 3 | Feb 12, 2026 | Adage Capital Management, L.P. | 13G | 5.8% | 4.27M | SEC |
| 4 | Feb 6, 2026 | Janus Henderson Group PLC | 13G | 10.1% | 7.44M | SEC |
| 5 | Nov 14, 2025 | Ikarian Capital, LLC | 13G | 11.0% | 3.54M | SEC |
| 6 | Aug 14, 2025 | Squadron Master Fund LP | 13G/A | 9.9% | 3.30M | SEC |
| 7 | May 1, 2025 | Squadron Master Fund LP | 13G | 6.2% | 2.05M | SEC |
| 8 | Nov 14, 2024 | Deep Track Capital, LP | 13G/A | 2.2% | 674.8K | SEC |
| 9 | Mar 6, 2024 | Perceptive Advisors LLC | 13G/A | — | — | SEC |
| 10 | Feb 14, 2024 | Deep Track Capital, LP | 13G/A | 6.8% | 2.04M | SEC |
31 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Relmada Therapeutics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Janus Henderson Group PLC | 11.06M | $76.89M |
| 2 | Squadron Capital Management LLC | 8.47M | $58.98M |
| 3 | Spruce Street Capital LP | 6.26M | $43.00M |
| 4 | Venrock Adviser, LLC | 4.84M | $33.71M |
| 5 | Adage Capital Partners Gp, L.L.C. | 4.76M | $33.15M |
| 6 | Orbimed Advisors LLC | 4.72M | $32.82M |
| 7 | Marshall Wace, LLP | 4.48M | $31.19M |
| 8 | Millennium Management LLC | 3.91M | $27.19M |
| 9 | Ra Capital Management, L.P. | 2.95M | $20.51M |
| 10 | Ikarian Capital, LLC | 2.69M | $18.71M |